Regeneron Pharmaceuticals REGN reported its Q3 earnings results on Thursday, November 3, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Regeneron Pharmaceuticals beat estimated earnings by 17.02%, reporting an EPS of $11.14 versus an estimate of $9.52.
Revenue was down $517.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.23 which was followed by a 1.02% increase in the share price the next day.
Here's a look at Regeneron Pharmaceuticals's past performance:
|Quarter||Q2 2022||Q1 2022||Q4 2021||Q3 2021|
To track all earnings releases for Regeneron Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.